Check out CincyTech portfolio company Eyas Medical Imaging in @modrnhealthcr.
Children’s hospitals are evolving into medtech hubs to close a critical gap: pediatric innovation currently lags nearly a decade behind adult devices. 🩺
Read more: https://t.co/NvveTAKrpY
🚀 MAJOR EXIT: We’re excited to announce that CincyTech portfolio company @LosantHQ has been acquired by @SUSE!
A huge win for the Cincinnati tech scene and a massive step forward for global Industrial IoT. Congrats to Charlie Key and the whole team!👏
https://t.co/xrxPILE0O5
A must-read from our partners at @Cincy_Tech!
As an @OhioLifeScience Ready city, #MasonOH is proud to play an active role in our region’s growing life sciences ecosystem. Through strategic partnerships to support innovation networks and research pipelines, biohealth thrives here.
Welcome to the team, William Butler-Croutwater! 🚀
As an Investment Analyst Intern, William will support our deal pipeline and portfolio. A @uofcincy student and leader at Bearcat Ventures, he's a great addition to CincyTech.
The biggest #JPM2026 win you might have missed: The FDA is easing manufacturing rules (21 CFR 211) for Cell & Gene Therapy. 🧬
Lower costs. Faster trials.
Partner Kenny Morand breaks down why 2026 is officially the year of #DataOverHype.
https://t.co/5030pSDYQl
Big moves at CincyTech! 🚀
We’re thrilled to promote Sean to VP, Investments. A team veteran since 2015, Sean will now head our tech & life sciences investment team, mentoring our analysts and guiding founders from early hurdles to successful exits.
Congrats, Sean!
#JPMWeek2026
Day 2:
1/ IPO Test: Eikon’s filing is the sector's litmus test. Will it open the floodgates?
2/ AI: $1B Lilly-Nvidia deal proves AI is the drug discovery backbone.
3/ FDA: Protocols eased for cell/gene therapy—faster & cheaper.
"From the Queen City to SF: CincyTech is at #JPM2026! 🌉
Life Sciences Partner Kenny Morand is on-site next week for the 44th Annual JPM Healthcare Conference, fueling the advancement of market-ready innovation. 🧬
Meet Kenny in SF to see how we’re moving the needle!
#JPM26
Reset. Refresh. Recharged. Refuel. 🔋🚀
While the year-end noise has settled, our momentum is just beginning. We took the time to reset so we could start 2026 with focus & purpose.
Full recap: https://t.co/c8RVbJVTVh
"The leap from academic discovery to commercial reality is fraught with failure in the life sciences."
Logan breaks down why #Cincinnati must engineer connectivity to ensure transformative discoveries reach the market.
Read more in @BusinessCourier: https://t.co/DzTDRl8Qgo
As 2025 draws to a close, the CincyTech team is reflecting on the incredible growth of our region’s ecosystem.
To our partners, founders, & supporters: Thank you.
Wishing you all a joyful holiday season & a Happy New Year! ✨
Making the hardest jobs in aviation safer. ✈️ Huge congrats to the @ActionStreamer team on their @BusinessInsider feature! See how their tech is modernizing maintenance for the USAF. 👇
https://t.co/73mkFRkNt4
Big congrats to CincyTech Life Sciences Fellow Issac Choi on his "New Idea" award from @Cancerfreekids !
His research targets Acute Myeloid Leukemia.
Simply put: He is hunting the "Queen Bee" of cancer cells. 🧬🔬
https://t.co/kpLAf81UUA
Today, we honor the courage, dedication, and sacrifice of all who have served in our armed forces.
We're continually grateful for the veterans who have defended our freedoms and continue to contribute to our communities in countless ways.
What gives Southwest Ohio an edge in AI? 👀
Hint: it’s not competing with Silicon Valley.
Doug Groh explains how our region is building AI advantages others can’t copy — with companies like Vixiv, @brandrankai , and @VurveyLabs.
@BusinessCourier
🔗 https://t.co/zyxTSwttYl
Kicking off Monday with big news from portfolio co. @EnableInjection!
They’ve announced a strategic partnership with @Incyte to use Enable’s enFuse® on-body delivery system for investigational ET & MF therapies.
Another win for Cincinnati innovation!👏
🔗https://t.co/OKb8WKzjfJ
Thank you @cintrifuse@Cincy_Tech Alloy, UC 1819 for a great kickoff of @StartupCincy. I enjoyed being a part of a panel on City As Lab with AirTrek, which has been leveraging the city to prove out a use case while providing the city with a valuable service at Lunkin Airport.
We’re proud to share that Neucore Bio has secured a $350K NIH STTR Phase I award to develop the FiXE™ exosome platform for targeted RNA delivery to Schwann cells, potentially paving the way for a CMT1A therapy.
https://t.co/2yDD4QTeEl